<DOC>
	<DOCNO>NCT00638118</DOCNO>
	<brief_summary>Examine relative potency , onset action duration action fexofenadine HCl 180 mg ( Allegra ) montelukast sodium 10 mg ( Singulair ) compare placebo skin wheal flare induce seasonal allergen .</brief_summary>
	<brief_title>Fexofenadine HCl 180 mg , Montelukast Sodium 10 mg Placebo Suppression Wheal Flare Induced Seasonal Allergen</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Terfenadine</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Male female subject , 15 55 year age , may participate . Subjects history seasonal allergic rhinitis ( due ragweed ; oak , elm maple ; grass ) previous 2 year . Positive seasonal allergen skin prick test ( duplicate seasonal allergen skin prick test ) summation flare great equal 20 mm large diluent control , summation wheal great equal 6 mm large diluent control screen visit 1 ( see Appendix 17.1 ) ; seasonal allergen test result great summation flare use subsequent seasonal allergen test . All female subject must negative urine pregnancy test screen visit . Female subject sexually active expect use one follow birth control method throughout study . Subjects must within 15 % normal body weight height BMI le 29.9 ( base NHLBI guideline ) . Subjects willing able adhere visit schedule study requirement . All female subject must negative urine pregnancy test treatment visit ( Visit 2 , 4 , 6 ) . Continues meet inclusion exclusion criterion . Asthma require treatment medication inhale , shortacting beta agonist . Significant sign symptom currently active allergic disease ( SAR , perennial allergic rhinitis , episodic allergic rhinitis ) . Upper respiratory tract infection , sinusitis , asthma flulike symptom within 2 week prior visit 1 . Subjects dermatographism skin condition might interfere interpretation skin test result . Subjects receive escalate dos immunotherapy , oral immunotherapy short course ( rush ) immunotherapy . Any excessive amount alcohol ( two drinks/day average ) . Any excessive use caffeine ( six cup coffee per day equivalent ) . Any history chronic alcohol moodaltering drug abuse . Any use tobacco/nicotine product within 90 day visit 1 . Any disease state surgery know affect gastrointestinal absorption drug . Known hypersensitivity investigational product drug similar chemical property . Subjects visit tan salon study . Subjects need use artificial tanning product study . Pregnancy . Breastfeeding . Regular treatment H1receptor antagonist last year study entry . No person child person directly associate administration study may participate study subject . Likelihood require treatment study period drug permit clinical study protocol . Treatment investigational product last 30 day study entry . Clinically relevant cardiovascular , hepatic , neurologic , endocrine , major systemic disease make implementation protocol interpretation study result difficult . Mental condition render subject unable understand nature , scope , possible consequence study . Subject unlikely comply protocol , e.g. , uncooperative attitude , inability return followup visit , unlikelihood completing study . Use follow drug within time indicated prior first dose visit : Systemic inject corticosteroid ( include oral , parenteral , intravenous , rectal ) 30 day ; Nasal inhale ocular corticosteroid 30 day ; Nasal inhale ipratropium bromide ( atropine ) , inhaled nedocromil , nasal , inhale , ophthalmic sodium cromolyn 14 day ; Agents antihistaminic/anticholinergic activity ( e.g . antidepressant , antipsychotic ) 14 day ; Leukotriene pathway modifier ( Accolate , Singulair , Zyflo ) 10 day ; Ocular antiallergy medication include lodoxamide ( Alomide ) , olopatadine ( Patanol ) , emedastine difumarate ( Emadine ) , levocabastine ( Livostin ) 10 day ; Nonsteroidal antiinflammatory ophthalmics include ketorolac ( Acular ) , flurbiprofen ( Ocufen ) , suprofen ( Profenal ) , diclofenac ( Voltaren ) 10 day ; Antihistamines include desloratadine ( Clarinex ) , loratadine ( Claritin ) 10 day ; Antihistamines include fexofenadine HCl ( Allegra ) , cetirizine ( Zyrtec ) , hydroxyzine , azelastine nasal spray ( Astelin ) , clemastine 7 day ; Other shortacting antihistamine chlorpheniramine drug antihistaminic activity 3 day ; OTC oral antihistamine , decongestant ( include pseudoephedrine decongestant ) , antihistamines/decongestant combination include cold , cough , sleep aid 3 day ; OTC ophthalmic decongestant , antihistamine , decongestant/antihistamine combination 3 day ; Other anticholinergic agent 3 day ; Immunotherapy injection 1 day . Other drug permit expect interfere ability subject participate study . Nonsteroidal antiinflammatory agent allow 2 day prior treatment visit day 25 hour postdose ( lowdose cardiac prophylaxis allow ) . Use medication agent specify may confound interpretation result : Caffeine within 6 hour prior visit ( coffee , tea , cola , soda , include Mountain Dew Surge ) Decaffeinated coffee , tea cola within 6 hour visit Alcohol within 24 hour prior study visit Chocolate within 6 hour prior visit Antacids within +/ minus2 hour investigational product dosing .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>